|
RNCOS Releases Report on Generic Drugs Market in Brazil
Brazil, one of the major emerging powers of the world, is marking its presence in almost every dimension of the world economy, including the generic drugs industry. Identifying the importance of the country in this significant domain, the leading market research firm, RNCOS, has come up with research report "Generic Drugs Market in Brazil (2007-2011)" to provide an updated and detailed account of the Brazilian generic drugs industry. It examines the chief reasons why all major generic players are heading to Brazil to manufacture and sell their drugs.
advertisement
Brazil is currently the largest market for generic drugs in Latin America and with the current scenario and positive future projections; it is likely to emerge amongst the most potential markets for generic drugs in the world.
The generic drugs market in Brazil witnessed an explosive growth of 38.8% and was valued in excess of US$ 1 Billion in 2006. The market was driven by several factors such as a supporting political environment, lower cost and patent expirations of several blockbuster drugs. The market is presently being dominated by domestic generic manufacturers; however, the presence of foreign firms in the market is increasing rapidly.
The growth of the market is expected to remain strong with generics expected to occupy 22.8% of the total market by 2011, enabling Brazil to become one of the largest generic markets in the world. However, despite the strong growth, several challenges still remain to be tackled, including the prevalence of cheaper non-bioequivalent "similar drugs", low prescriptions from the private sector, and low penetration levels in the private sector.
Key Issues & Facts Analyzed
- Evaluation of past, c urrent and future market trends.
- Discussion about the size and growth of the market.
- Analysis of healthcare indicators.
- Future prospects of the generics market.
- Analysis of various challenges and opportunities before the industry.
- Profile discussion of key players in this sector.
Key Players Analyzed
This section provides the overview, key facts, and financial information of prominent players in the Brazil Generics Market, such as Medley, EMS Sigma Pharma, Eurofarma Laboratorios Ltd, Aché Pharmaceutical Laboratories S/A and Ranbaxy.
About RNCOS E-Services Pvt Ltd.
RNCOS, incorporated in the year 2002, is an industry research firm. It has a team of industry experts who analyze data collected from credible sources. They provide industry insights and analysis that helps corporations to take timely and accurate business decision in today's globally competitive environment.
For more information visit:
http://www.rncos.com/Report/IM572.htm
Current Industry News:
http://www.rncos.com/blog
Would you like to see your news and articles here? GO>>
Disclaimer: The views and opinions expressed in the research published are those of the individual companies and writers and not necessarily those of Investorideas.com®, or any of the industry sector portals . At the time of publication, writers may hold positions in the stocks or companies mentioned.
Investorideas.com® or any of the industry sector portals cannot assure accuracy of the research presented. Investors are encouraged to research and verify facts and under no circumstances is Investorideas.com® endorsing the content as a recommendation to buy or sell stock.
|
